Adicet Bio (ACET) EBT Margin (2019 - 2022)

Adicet Bio's EBT Margin history runs 4 years deep, the most recent figure standing at 18.48% for Q1 2022.

• In Q1 2022, EBT Margin rose 55520.0% year-over-year to 18.48%; the TTM figure through Dec 2022 stood at 279.28% (down 6905.0% YoY), while the FY2022 annual figure was 279.27%, up 35921.0% from the prior year.
• EBT Margin for Q1 2022 stood at 18.48%, up from 289.39% in the prior quarter.
• The five-year high for EBT Margin was 561.87% in Q4 2020, with the low at 536.72% in Q1 2021.
• The 4-year median for EBT Margin is 0.4% (2021), against an average of 82.27%.
• The sharpest annual moves came in 2021 and 2022: EBT Margin tumbled 85126 bps in 2021, then soared 55520 bps in 2022.
• Adicet Bio's EBT Margin stood at 119.05% in 2019, then soared by 372 bps to 561.87% in 2020, then plunged by 152 bps to 289.39% in 2021, then surged by 106 bps to 18.48% in 2022.
• Business Quant data shows ACET's EBT Margin at 18.48% in Q1 2022, 289.39% in Q4 2021, and 0.04% in Q2 2021.